Double-blind clinical evaluation of UCB 1549 in treatment of Parkinson's disease.

Benzer Materyaller

• Imipramine in Treatment of Parkinsonism: a Double-blind Placebo Study
  Yazar:: Strang, R. R.
  Baskı/Yayın Bilgisi: (1965)
• Zishenpingchan granules for the treatment of Parkinson’s disease: a randomized, double-blind, placebo-controlled clinical trial
  Yazar:: Ye, Qing, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study
  Yazar:: Katzenschlager, R, ve diğerleri
  Baskı/Yayın Bilgisi: (2004)
• Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease.
  Yazar:: Barbeau, A., ve diğerleri
  Baskı/Yayın Bilgisi: (1976)
• Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson’s disease trial
  Yazar:: Gendelman, Howard E., ve diğerleri
  Baskı/Yayın Bilgisi: (2017)